Funding for this research was provided by:
Fondazione AIRC (ID. 21354 project)
5 per Mille 2019 (- ID. 22759 program)
5 per Mille 2019, Veneto Institute of Oncology IOV-IRCCS (BIOV19ROSATO)
the Ministry of Health-Alliance Against Cancer (RCR-2019-23669115, WG6-ACC-2020)
Received: 24 June 2022
Accepted: 30 August 2022
First Online: 20 September 2022
: The study was approved by the ethic committees for clinical experimentation (CEP) of Treviso and Belluno provinces (Ethic votes: 345/AULSS9 and 421/AULSS9) and Friuli Venezia Giulia region (Ethic votes: CEUR-Os-041-ASUITS), and all patients signed an informed consent.
: All authors agreed with submission of the manuscript for publication and agree to be accountable for all aspect of the manuscript.
: The authors declare that they have no competing interests.